COVID-19 crisis as catalyst for telemedicine for chronic neurological disorders

0

What The Viewpoint Says: The reasons for and reality of a rapid advance toward telemedicine in neurology during the coronavirus disease 2019 pandemic is described in this Viewpoint article.

Authors: Bastiaan R. Bloem, M.D., Ph.D., of Radboud University Medical Centre in the Netherlands, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaneurol.2020.1452)

Editor’s Note: The article includes conflict of interest disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

###

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2020.1452?guestAccessKey=934ee1ba-2076-4ed1-8e54-0c04cd42b1e9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042420

Media Contact
JAMA Network Media Relations

[email protected]

Leave A Reply

Your email address will not be published.